Beta
240866

Review on Ehrlich Ascites Carcinoma in Mice and Cancer Treatment with Special Reference to The Potential Protective and Therapeutic Effects of Hesperidin Versus Cisplatin

Article

Last updated: 22 Jan 2023

Subjects

-

Tags

Clinical pathology

Abstract

Ehrlich Ascites Carcinoma (EAC) is an experimental transplantable neoplasm, which discovered firstly as a mammary tumor in mouse. Like other cancers growing in body cavities, EAC cells fill the mouse peritoneum by rapid cells division causing a local inflammatory reaction, with increasing vascular permeability leading to intense edema formation, cellular migration and progressive ascitic fluid formation.Cisplatin (Cis) is one of the most frequently used antineoplastic agents for various types of cancer. Cisplatin exhibited its antitumor effect via generating DNA adducts, which in turn leads to cell cycle arrest and initiating apoptotic signaling pathway. Unfortunately, the use of Cis in cancer patients is now strictly regulated due to the fact that it is linked to a variety of adverse effects, including nephrotoxicity, severe nausea and vomiting, myelosuppression, ototoxicity, and neurotoxicity. Furthermore, many cisplatin-treated patients who relapsed after a period of recovery have developed drug resistance. Natural products have played an essential role in health promotion and illness prevention for many years. There is a lot of data that is linked to the creation of natural product-based medicines that have been utilized to inhibit, reverse, or slow down the carcinogenesis process. Hesperidin (Hesp) is a bioflavonoid found primarily in citrus fruits such as clementine, lemons, mandarins, grapefruit, and oranges. Hesperidin is proposed to provide a wide range of health benefits including anti-inflammatory and antimicrobial properties, as well as cancer treatment.  

DOI

10.21608/jcvr.2022.240866

Keywords

Ehrlich Ascites Carcinoma, EAC, Chemotherapy, Cisplatin, Hesperidin

Authors

First Name

Nahed

Last Name

Saleh

MiddleName

-

Affiliation

Department of Clinical Pathology, Faculty of Veterinary Medicine, University of Sadat City, Minufiya, Egypt.

Email

nahed.thabet@vet.usc.edu.eg

City

-

Orcid

-

First Name

Tamer

Last Name

Allam

MiddleName

-

Affiliation

Department of Clinical Pathology, Faculty of Veterinary Medicine, University of Sadat City, Minufiya, Egypt.

Email

tamer_sma@yahoo.com

City

-

Orcid

-

First Name

Abdelfattah

Last Name

Abdelfattah

MiddleName

-

Affiliation

Department of Clinical Pathology, Faculty of Veterinary Medicine, University of Sadat City, Minufiya, Egypt.

Email

abdelfattah.mohamed@vet.usc.edu.eg

City

Sadat city

Orcid

0000-0002-7424-8151

First Name

Nermeen

Last Name

El-Borai

MiddleName

-

Affiliation

Department of Forensic Medicine & Toxicology, Faculty of veterinary medicine, University of Sadat City, Minufiya, Egypt.

Email

nermeen.elborai@vet.usc.edu.eg

City

-

Orcid

-

Volume

4

Article Issue

1

Related Issue

34447

Issue Date

2022-04-01

Receive Date

2022-02-04

Publish Date

2022-04-01

Page Start

47

Page End

57

Print ISSN

2636-4018

Online ISSN

2636-4026

Link

https://jcvr.journals.ekb.eg/article_240866.html

Detail API

https://jcvr.journals.ekb.eg/service?article_code=240866

Order

7

Type

Original Article

Type Code

799

Publication Type

Journal

Publication Title

Journal of Current Veterinary Research

Publication Link

https://jcvr.journals.ekb.eg/

MainTitle

-

Details

Type

Article

Created At

22 Jan 2023